Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Pearson

Showing results (71-80 of 169) with videos related to

Pageof 17
Sort By:
Journal of Comparative Effectiveness Research|November 14, 2024
Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United StatesSharon Phares, Mark Trusheim, Sarah K Emond, et al.
Journal of Comparative Effectiveness Research|July 13, 2017
Indication-specific pricing of pharmaceuticals in the US healthcare systemSteven D Pearson, William B Dreitlein, Chris Henshall, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
On Track: a database for evaluating the outpatient clinical experience of internal medicine residency trainingThomas D Sequist, Surya Singh, Anne Pereira, et al.
Journal of Managed Care & Specialty Pharmacy|May 29, 2019
A Summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory CouncilIfeoma S Otuonye, Reiner Banken, Varun M Kumar, et al.
Hepatology (Baltimore, Md.)|September 12, 2015
Tackling the hepatitis C cost problem: A test case for tomorrow's curesRachel E Simon, Steven D Pearson, Chin Hur, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 28, 2024
How Do the Institute for Clinical and Economic Review's Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee's Assessments of Added Benefit? A Qualitative StudyMichael J DiStefano, Steven D Pearson, David M Rind, et al.
Journal of Comparative Effectiveness Research|September 28, 2019
Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy SummitSteven D Pearson, Celia Segel, Amanda Cole, et al.
Journal of Managed Care & Specialty Pharmacy|April 1, 2020
The Authors RespondDaniel R Touchette, Foluso Agboola, Steven J Atlas, et al.
Journal of Comparative Effectiveness Research|November 17, 2017
Gene therapy: evidence, value and affordability in the US health care systemGrace Hampson, Adrian Towse, Steven D Pearson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 22, 2022
The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19Melanie D Whittington, Steven D Pearson, David M Rind, et al.
Pageof 17

Showing results (71-80 of 169) with videos related to

Sort By:
Pageof 17
Journal of Comparative Effectiveness Research|November 14, 2024
Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United StatesSharon Phares, Mark Trusheim, Sarah K Emond, et al.
Journal of Comparative Effectiveness Research|July 13, 2017
Indication-specific pricing of pharmaceuticals in the US healthcare systemSteven D Pearson, William B Dreitlein, Chris Henshall, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
On Track: a database for evaluating the outpatient clinical experience of internal medicine residency trainingThomas D Sequist, Surya Singh, Anne Pereira, et al.
Journal of Managed Care & Specialty Pharmacy|May 29, 2019
A Summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory CouncilIfeoma S Otuonye, Reiner Banken, Varun M Kumar, et al.
Hepatology (Baltimore, Md.)|September 12, 2015
Tackling the hepatitis C cost problem: A test case for tomorrow's curesRachel E Simon, Steven D Pearson, Chin Hur, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 28, 2024
How Do the Institute for Clinical and Economic Review's Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee's Assessments of Added Benefit? A Qualitative StudyMichael J DiStefano, Steven D Pearson, David M Rind, et al.
Journal of Comparative Effectiveness Research|September 28, 2019
Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy SummitSteven D Pearson, Celia Segel, Amanda Cole, et al.
Journal of Managed Care & Specialty Pharmacy|April 1, 2020
The Authors RespondDaniel R Touchette, Foluso Agboola, Steven J Atlas, et al.
Journal of Comparative Effectiveness Research|November 17, 2017
Gene therapy: evidence, value and affordability in the US health care systemGrace Hampson, Adrian Towse, Steven D Pearson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 22, 2022
The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19Melanie D Whittington, Steven D Pearson, David M Rind, et al.
Pageof 17